SATELLOS BIOSCIENCE INC.

Profile

Company Names

SATELLOS BIOSCIENCE INC.
ICO THERAPEUTICS INC

Addresses

ROYAL BANK PLAZA, S. TOWER, 200 BAY ST., SUITE 2800, TORONTO, A6 M5J 2J1

65 FRONT STREET EAST, SUITE 201, TORONTO, A6 M5E 1B5

777 HORNBY STREET, 6TH FLOOR, VANCOUVER, A1 V6Z 1S4

777 HORNBY STREET, VANCOUVER, A1 V6Z 1S4

760-777 HORNBY STREET, VANCOUVER, XX V6Z 1S4

760-777 HORNBY STREET, VANCOUVER, A1 V6Z 1S4

Phone Numbers

416-708-0522
905-336-6128
604-657-3882
604-602-9414

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

2006

State Incorporated:

BRITISH COLUMBIA, CANADA

Total Amount Raised:

$64,204,248.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2024-12-20 
$25,016,264.00 
$25,016,264.00 
$0.00 
Equity 
7
2023-05-10 
$33,292,573.00 
$33,292,573.00 
$0.00 
Equity 
6
2022-09-13 
$99,161.00 
$2,101,450.00 
$2,002,289.00 
Equity 
5
2019-08-19 
$187,999.00 
$2,511,657.00 
$2,323,658.00 
Equity 
4
2019-02-22 
$151,826.00 
$971,685.00 
$819,859.00 
Equity 
3
2014-01-27 
$2,027,393.00 
$7,930,682.00 
$5,903,289.00 
Equity 
2
2011-11-02 
$125,914.00 
$125,914.00 
$0.00 
Equity 
1
2009-10-29 
$3,303,118.00 
$3,303,118.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
RIMA 
 
AL-AWAR 
DIRECTOR
RICHARD 
 
BARKER 
DIRECTOR
BRIAN 
 
BLOOM 
DIRECTOR
MICHAEL 
ROBERT 
CROSS 
EXECUTIVE OFFICER
FRANK 
 
GLEESON 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
J. 
ROBERT 
HALL 
EXECUTIVE OFFICER
PETER 
 
HNIK 
EXECUTIVE OFFICER
DOUGLAS 
G. 
JANZEN 
DIRECTOR
BILL 
 
JAROSZ 
DIRECTOR
SUSAN 
 
KOPPY 
DIRECTOR
PHILIP 
D. 
LAMBERT 
EXECUTIVE OFFICER
MICHAEL 
 
LIGGETT 
EXECUTIVE OFFICER, DIRECTOR
WILLIAM 
 
MCVICAR 
DIRECTOR
JOHN 
MEEKISON 
EXECUTIVE OFFICER
W. 
JOHN 
MEEKISON 
EXECUTIVE OFFICER
ADAM 
 
MOSTAFA 
DIRECTOR
SANTA JEREMY 
 
ONO 
EXECUTIVE OFFICER
ANDREW 
 
RAE 
EXECUTIVE OFFICER, DIRECTOR
ANDREW 
J. 
RAE 
EXECUTIVE OFFICER, DIRECTOR
MICHAEL 
 
RUDNICKI 
EXECUTIVE OFFICER, PROMOTER
COURTNEY 
 
WELLS 
EXECUTIVE OFFICER
WARREN 
 
WHITEHEAD 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-12-20 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-05-10 
D
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2022-09-13 
D
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2019-08-19 
D
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2019-02-22 
D
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2014-01-27 
D/A
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2011-11-02 
D
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2011-11-02 
D/A
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2009-10-29 
D
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2009-10-29 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
HAYWOOD SECURITIES INC.
NONE
HAYWOOD SECURITIES (USA) INC.
NONE
NONE
CANACCORD GENUITY LLC
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
375
NONE
NONE
VERSANT PARTNERS USA, INC.
NONE
NONE
LOEWEN, ONDAATJE, MCCUTCHEON USA LIMITED